Original document(6 pages) Authorized document(6 pages) 中文版
    The Resina Draconis preparation is one dispersive solid prepared through one mixing process to disperse Resina Draconis into very fine particle by means of water soluble dispersant. It has high water solubility and is easy to be absorbed by human body, so that it has very low consumption, about six to ten times lower than that of original Resina Draconis powder, in the case of reaching identical curative effect. Thus, the Resina Draconis preparation has the features of small dosage and high curative effect and this is favorable to protect the resource of Resina Draconis as one of valuable Chinese medicinal materials.
Application Number
申请号
00114031 Application Date
申请日
2000.01.21
Title 名称 Resina Draconis preparation as one Chinese medicine and its preparation process
Publication Number
公开号
1265321 Publication Date
公开日
2000.09.06
Approval Pub. Date Granted Pub. Date 2002.12.25
International Classification 分类号 A61K9/14,A61K35/78
Applicant(s) Name
申请人
Guangdong Mingsheng Pharmaceutical Co., Ltd.
Address 地址 510240
Inventor(s) Name 发明人
Attorney & Agent 代理人 lin canzhi

  
Natural herbal medicine composition with the functions of stopping itching, disinfection and antiphlogosis and its preparation
Medicine for dredging the meridian passage and softening mass and its preparation
Xiancaoteng capsule made of korean epimedium herb, liquorice root and common threewingnut root and its preparation
Hantongling capsule for treatment of wind-cold and wind-dampness syndrome
Kidney-invigorating and bone strengthening capsule
Medicine mixture with rhubarb and other herbal medicine material
Liver-invigorating detoxication pill for treating hepatitis B
Dermatosis treating medicine
Psoriasis treating medicine
Alopecia treating medicine
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.